Iterative Health vs Magentiq Eye (2026)
Both put computer vision on the colonoscopy video feed, and only one of them still treats that as the business. Magentiq is a focused device company: an on premise appliance between the scope and the monitor, inference performed locally in real time, authorization in three jurisdictions maintained across versions, and an international multicenter trial behind it. Iterative Health now describes itself mainly as a company accelerating clinical research through its network, with SKOUT, its cleared polyp detection device, reached from a footer link. That shift matters for a gastroenterology unit: buying a device from a company whose attention has moved is a support and roadmap question to put to the vendor directly. For detection alone, Magentiq keeps the video in the room and the device at the center of what it sells.
- The company now leads with clinical research, so a buyer is engaging with a research network as well as a detection device.
- For a health system interested in trial participation as well as detection, the research side is the larger part of what is on offer.
- SKOUT remains available and cleared, so the capability has not been withdrawn even as the emphasis moved.
- The device sits between the colonoscope and the monitor performing inference locally in real time on an on premise appliance, so no video leaves the procedure room.
- It holds authorization in three jurisdictions, maintained across product versions.
- An international multicenter trial stands behind it, addressing the variation between endoscopists that matters in this procedure.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Iterative Health and Magentiq Eye are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Iterative Health | Magentiq Eye |
|---|---|---|
| Primary category | Radiology & Imaging AI | Radiology & Imaging AI |
| Founded | Not recorded | 2014 |
| Headquarters | Cambridge, Massachusetts | Haifa, Israel |
| Website | iterative.health | magentiq.com |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Iterative Health, legally Iterative Scopes, Inc., is based in Cambridge, Massachusetts and runs two businesses under one name: a cleared AI device for colonoscopy and a clinical research site network. Its website leads with the research network, and the device is one of three solutions listed in the footer.
Source: AI Health Index, September 2026
Magentiq Eye is a Haifa company founded in 2014 by Dror Zur that builds real time computer aided detection for colonoscopy. Its product, MAGENTIQ-COLO (registered with the FDA as the ME-APDS automatic polyp detection system), takes the video feed from the colonoscope, analyzes each frame with a deep learning model during the procedure, and returns the video to the monitor with suspected polyps marked, so the endoscopist walks past fewer adenomas.
Source: AI Health Index, September 2026
Questions buyers ask
How do Iterative Health and Magentiq Eye handle patient data?
For Iterative Health, the company's privacy policy, updated 1 September 2026, covers personal information from business customers and website visitors, says information is kept as long as necessary to provide the services and protected by industry standard measures, and lists categories of service providers, including platform hosting and security monitoring, without naming them.
With Magentiq Eye, the 510(k) summary describes the device acquiring the endoscope's video and processing it in real time in a unit that sits in the video path of the procedure room, with the highlighted video shown on local monitors. It does not say whether video is stored on the unit, whether recordings are transmitted after the procedure, for how long anything is retained, or whether recorded procedures are used to improve the model. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 28, 2026. No vendor pays for placement.
Which settings and specialties do Iterative Health and Magentiq Eye cover?
Iterative Health appears among clinical trials AI vendors because its research network uses machine learning to prescreen patients for trial eligibility; its cleared product is SKOUT, a colonoscopy device that reads live endoscopic video to find polyps.
For Magentiq Eye, coverage is white light screening and surveillance colonoscopy in gastroenterology (K223473), deployed in hospital endoscopy units and ambulatory centers across the US, Europe and Israel, with a PENTAX Medical partnership covering EMEA, JAPAC, Latin America and North America. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 28, 2026. No vendor pays for placement.
What evidence is published for Iterative Health and Magentiq Eye?
With Iterative Health, the K213686 clearance summary reports 1,359 patients in the modified intention to treat population, 682 colonoscopies with SKOUT and 677 without, no adverse events or complications, and, as a second primary endpoint, positive percent agreement of 70.9 percent with the device against 75.7 percent without.
In Magentiq Eye's case, the international trial ran for fourteen months across ten centers in Europe, the United States and Israel, with 31 endoscopists and about 950 randomized patients, was registered in advance, and was published in Lancet Digital Health in February 2024; the 510(k) summary (K223473) reports its results. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 28, 2026. No vendor pays for placement.
How much do Iterative Health and Magentiq Eye leave to the clinician?
For Iterative Health, the K213686 indication is a computer aided detection tool that gives polyp location information to assist trained gastroenterologists during colonoscopy in adults having screening or surveillance, for white light colonoscopy only.
With Magentiq Eye, the cleared indication (K223473) is an adjunct that assists the endoscopist in identifying lesions by highlighting regions with visual characteristics of mucosal abnormalities, not a replacement for histopathological sampling, limited to white light imaging. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 28, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
Read the corporate direction carefully before buying either: one company presents itself primarily as a clinical research organization with the device in a footer, which changes what a purchaser is committing to and how the device is likely to be supported. Neither company publishes business associate terms or a security attestation, and Magentiq publishes no health privacy statement; its architecture keeps video local, which removes much of what those documents would govern. Neither publishes pricing, and for a procedure room appliance the question of whether the unit is sold, leased or charged per procedure materially changes the economics.